stockrow
Friday 6 November 2026
Export GMED’s income statement to Excel — free account
Globus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- +19.3%
- Free cash flow
- +10.1%
Quarter to September 2026, against a year earlier
70.68
10.76
−13.21%
Follow GMED
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
22.95 | 38.54 | 27.05 | 37.27 | 62.71 | 48.78 | 38.71 | 45.05 | 110.28 | 21.94 |
Piotroski F-Score |
5 | 6 | 6 | 3 | 5 | 7 | 6 | 3 | 5 | 9 |
Altman Z-Score |
17.57 | 24.06 | 24.51 | 29.31 | 24.34 | 22.29 | 21.65 | 4.39 | 7.46 | 11.30 |
P/S ratio |
4.20 | 6.53 | 5.94 | 7.43 | 8.15 | 7.59 | 7.19 | 3.83 | 4.46 | 4.02 |
P/FCF ratio |
22.18 | 38.56 | 33.37 | 57.67 | 47.58 | 33.15 | 70.39 | 36.39 | 27.70 | 20.75 |
Altman Z″-Score (non-manufacturers) |
15.54 | 15.62 | 16.62 | 16.81 | 14.34 | 13.48 | 13.73 | 6.73 | 6.66 | 10.06 |
Beneish M-Score |
(2.40) | (2.47) | (2.26) | (2.38) | (2.84) | (2.61) | (2.22) | (1.83) | (2.59) | (2.31) |
P/Operating CF |
90.01 | 92.66 | 95.65 | 107.50 | 80.18 | 95.38 | 114.89 | 57.43 | 53.37 | 47.49 |
P/B ratio |
2.85 | 4.29 | 3.57 | 4.16 | 4.27 | 4.18 | 3.98 | 1.50 | 2.69 | 2.58 |
Price to Tangible BV |
3.57 | 5.43 | 4.35 | 4.89 | 5.09 | 4.87 | 4.64 | 3.67 | 5.76 | 4.93 |
EV/Sales |
3.69 | 5.95 | 5.47 | 7.04 | 7.61 | 7.13 | 6.76 | 3.78 | 4.44 | 4.12 |
EV/EBITDA |
10.38 | 18.26 | 18.33 | 24.72 | 34.35 | 27.94 | 22.91 | 16.53 | 16.93 | 15.47 |
EV/Operating CF |
14.07 | 23.77 | 21.45 | 32.15 | 30.22 | 24.74 | 38.71 | 24.33 | 21.51 | 16.07 |
EV/FCF |
19.46 | 35.09 | 30.70 | 54.62 | 44.46 | 31.15 | 66.17 | 35.86 | 27.63 | 21.28 |
Quick Ratio |
4.84 | 5.36 | 5.04 | 4.25 | 4.76 | 4.35 | 4.17 | 2.61 | 1.72 | 2.61 |
Current Ratio |
6.43 | 6.67 | 6.56 | 6.17 | 6.80 | 6.17 | 6.18 | 4.88 | 2.54 | 4.26 |
Net Debt/EBITDA |
(1.45) | (1.80) | (1.60) | (1.38) | (2.41) | (1.79) | (1.48) | (0.28) | (0.68) | (0.71) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.13% | 0.30% | 0.26% | 0.00% | 8.21% | 8.44% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.11 | 0.00 |
Asset Turnover |
0.64 | 0.63 | 0.60 | 0.55 | 0.49 | 0.53 | 0.51 | 0.44 | 0.49 | 0.56 |
Operating CF/Net income |
1.42 | 1.48 | 1.16 | 1.11 | 1.94 | 1.85 | 0.94 | 1.98 | 5.06 | 1.40 |
Capex/Depreciation |
(0.88) | (1.13) | (1.26) | (1.37) | (1.00) | (0.78) | (1.01) | (0.35) | (0.23) | (0.58) |
| 13.49% | 11.93% | 14.53% | 11.99% | 7.03% | 9.19% | 10.60% | 4.20% | 2.52% | 12.29% | |
| 11.85% | 10.70% | 13.15% | 10.96% | 6.37% | 8.20% | 9.43% | 3.43% | 1.99% | 10.19% | |
ROIC |
17.80% | 17.03% | 12.51% | 9.84% | 6.42% | 8.25% | 10.17% | 2.14% | 2.78% | 7.47% |
Return on Tangible Assets |
18.70% | 16.01% | 22.15% | 20.00% | 11.14% | 15.78% | 17.81% | 5.82% | 5.47% | 24.54% |
Average Days of Receivables |
61.99 | 71.97 | 73.90 | 75.49 | 68.51 | 63.11 | 77.55 | 117.49 | 83.79 | 92.36 |
Research and Development Expense of Revenue |
7.90% | 6.87% | 7.78% | 7.65% | 10.71% | 10.16% | 7.14% | 7.91% | 6.50% | 5.01% |
Selling, General and Administrative Expense of Revenue |
39.39% | 42.11% | 43.70% | 45.17% | 44.96% | 42.60% | 42.25% | 41.05% | 38.95% | 40.10% |
Intangible Assets out of Total Assets |
0.18 | 0.19 | 0.16 | 0.14 | 0.15 | 0.13 | 0.13 | 0.46 | 0.42 | 0.41 |
Share Based Compensation of Revenue |
2.02% | 2.31% | 3.07% | 3.32% | 3.43% | 3.19% | 3.21% | 3.36% | 2.15% | 1.69% |
Graham Net Nets |
0.18 | 0.12 | 0.12 | 0.10 | 0.10 | 0.09 | 0.10 | 0.14 | 0.10 | 0.12 |
Graham Number |
14.54 | 15.92 | 20.88 | 22.42 | 18.91 | 23.99 | 27.96 | 30.64 | 22.79 | 55.03 |
Earnings Yield |
4.36% | 2.59% | 3.70% | 2.68% | 1.59% | 2.05% | 2.58% | 2.22% | 0.91% | 4.56% |
Free Cash Flow Yield |
4.51% | 2.59% | 3.00% | 1.73% | 2.10% | 3.02% | 1.42% | 2.75% | 3.61% | 4.82% |
Revenue per Share |
5.90 | 6.61 | 7.28 | 7.92 | 8.00 | 9.51 | 10.18 | 13.87 | 18.56 | 21.74 |
Operating CF per Share |
1.55 | 1.65 | 1.86 | 1.73 | 2.02 | 2.74 | 1.78 | 2.15 | 3.84 | 5.57 |
Capex per Share |
(0.43) | (0.53) | (0.56) | (0.71) | (0.65) | (0.56) | (0.74) | (0.69) | (0.85) | (1.29) |
Free Cash Flow per Share |
1.12 | 1.12 | 1.30 | 1.02 | 1.37 | 2.18 | 1.04 | 1.46 | 2.99 | 4.28 |
Cash per Share |
3.04 | 3.88 | 3.47 | 3.14 | 4.33 | 4.40 | 4.44 | 4.58 | 6.56 | 4.12 |
Shareholders Equity per Share |
8.70 | 10.06 | 12.11 | 14.14 | 15.28 | 17.29 | 18.38 | 35.35 | 30.78 | 33.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.70 | 10.06 | 12.11 | 14.14 | 15.28 | 17.29 | 18.38 | 35.35 | 30.78 | 33.82 |
Free Cash Flow |
106.91 | 107.76 | 126.95 | 101.23 | 135.14 | 219.38 | 104.42 | 165.23 | 405.21 | 579.02 |
Working Capital |
433.87 | 527.27 | 534.56 | 576.07 | 700.97 | 724.35 | 824.14 | 1,523.03 | 1,321.35 | 1,627.11 |
Capital Expenditures |
(40.91) | (51.30) | (54.70) | (70.75) | (63.66) | (56.90) | (74.05) | (78.27) | (115.43) | (174.42) |
Net Current Asset Value |
418.21 | 509.62 | 515.53 | 557.84 | 648.58 | 648.64 | 753.59 | 827.25 | 1,102.84 | 1,396.10 |
EV/EBIT |
13.50 | 23.36 | 23.01 | 32.14 | 53.91 | 39.75 | 30.31 | 44.50 | 67.45 | 25.24 |
Capex to Sales |
0.07 | 0.08 | 0.08 | 0.09 | 0.08 | 0.06 | 0.07 | 0.05 | 0.05 | 0.06 |
Price to Operating Income |
15.38 | 25.67 | 25.02 | 33.94 | 57.70 | 42.30 | 32.25 | 45.15 | 67.63 | 24.60 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.37 | 0.32 | 0.25 | 0.26 | 0.29 | 0.33 | 0.30 | 0.38 | 0.88 | 0.54 |
Cash ROIC |
9.52% | 8.03% | 8.32% | 5.90% | 6.97% | 10.02% | 4.56% | 3.35% | 7.35% | 11.29% |
Accounts Receivable Turnover |
6.19 | 5.75 | 5.29 | 5.12 | 5.08 | 6.11 | 5.34 | 4.34 | 4.65 | 4.45 |
Accounts Payable Turnover |
8.06 | 7.08 | 6.26 | 7.13 | 10.16 | 11.91 | 9.09 | 11.82 | 15.71 | 11.01 |
Inventory Turnover |
1.24 | 1.36 | 1.33 | 1.10 | 1.02 | 1.03 | 0.98 | 0.96 | 1.37 | 1.35 |
Average Days of Payables |
47.34 | 60.74 | 59.29 | 49.92 | 30.56 | 33.50 | 49.96 | 37.73 | 26.48 | 37.67 |
Days of Inventory on Hand |
305.35 | 263.00 | 300.53 | 398.14 | 384.62 | 361.61 | 413.79 | 564.73 | 232.38 | 289.35 |
Average Receivables |
91.07 | 110.59 | 134.87 | 153.39 | 155.26 | 156.88 | 191.48 | 361.09 | 541.60 | 661.00 |
Average Payables |
16.72 | 21.26 | 25.47 | 25.25 | 21.41 | 20.08 | 29.03 | 46.39 | 65.89 | 86.99 |
Average Inventory |
108.98 | 110.55 | 119.83 | 163.78 | 212.73 | 233.08 | 267.99 | 573.56 | 753.68 | 709.26 |
Average Assets |
880.87 | 1,003.07 | 1,189.59 | 1,416.37 | 1,605.78 | 1,818.37 | 2,016.69 | 3,581.10 | 5,168.92 | 5,277.26 |
Average Common Equity |
773.70 | 899.93 | 1,076.65 | 1,293.98 | 1,454.37 | 1,623.84 | 1,793.88 | 2,922.17 | 4,087.65 | 4,375.29 |
Columns are period end dates · fundamentals updated 5 Nov 2026